Download PDF

1. Company Snapshot

1.a. Company Description

Redcare Pharmacy NV owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands.It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements.The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023.


The company was founded in 2001 and is headquartered in Sevenum, the Netherlands.

Show Full description

1.b. Last Insights on RDC

Redcare Pharmacy NV faces challenges due to a lack of recent catalysts, with the last notable event being an analyst optimism on potential profitability. However, the company's insider ownership, while a positive signal, has not translated into tangible growth drivers. The European market's mixed landscape and potential policy shifts by the European Central Bank may also impact the company's operations. Furthermore, the absence of significant developments, such as new product launches or strategic acquisitions, may hinder its progress.

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Card image cap

Analysts Are Optimistic We'll See A Profit From Redcare Pharmacy NV (ETR:RDC)

Feb -10

Source:

Card image cap

Top European Growth Companies With Strong Insider Ownership

Jan -20

Source:

Card image cap

3 European Growth Companies With Up To 36% Insider Ownership

Dec -19

Source:

Card image cap

European Growth Companies With High Insider Ownership For November 2025

Nov -20

Source:

Card image cap

Redcare Pharmacy appoints Hendrik Krampe as CFO

Nov -11

Source:

Card image cap

Change in Redcare Pharmacy's Managing Board: New CFO Hendrik Krampe

Nov -10

Source:

Card image cap

Redcare Pharmacy NV (ETR:RDC) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov -01

Source:

Card image cap

European Growth Companies Insiders Are Investing In

Oct -22

Source:

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (7.41%)

6. Segments

DACH

Expected Growth: 7.18%

DACH region's growing elderly population, increasing healthcare expenditure, and rising demand for chronic disease management drive Redcare Pharmacy NV's 7.18% growth. Additionally, the region's strong economy, favorable reimbursement policies, and increasing adoption of digital healthcare solutions contribute to the company's expansion.

International

Expected Growth: 8.37%

Redcare Pharmacy NV's 8.37% international growth is driven by increasing demand for specialty medicines, expansion into emerging markets, and strategic partnerships with local healthcare providers. Additionally, the company's investment in digital healthcare platforms and e-commerce capabilities has enhanced customer reach and accessibility, contributing to its growth momentum.

7. Detailed Products

Prescription Medication

Redcare Pharmacy NV offers a wide range of prescription medications for various health conditions, including chronic diseases and acute illnesses.

Over-the-Counter (OTC) Medication

The pharmacy offers a variety of OTC medications for common health issues, such as pain relief, allergies, and digestive problems.

Vitamins and Supplements

Redcare Pharmacy NV provides a range of vitamins and supplements to support overall health and wellness.

Health and Beauty Products

The pharmacy offers a selection of health and beauty products, including skincare, haircare, and personal care items.

Medical Equipment and Supplies

Redcare Pharmacy NV provides medical equipment and supplies, such as wheelchairs, walkers, and diabetic testing strips.

Consultation Services

The pharmacy offers consultation services with licensed pharmacists and healthcare professionals.

8. Redcare Pharmacy NV's Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for Redcare Pharmacy NV is moderate due to the presence of alternative pharmacies and online retailers.

Bargaining Power Of Customers

The bargaining power of customers is low due to the lack of price sensitivity and the importance of convenience in the pharmacy industry.

Bargaining Power Of Suppliers

The bargaining power of suppliers is moderate due to the presence of multiple suppliers and the importance of maintaining relationships with them.

Threat Of New Entrants

The threat of new entrants is high due to the relatively low barriers to entry and the attractiveness of the pharmacy industry.

Intensity Of Rivalry

The intensity of rivalry is high due to the presence of multiple competitors and the importance of differentiating oneself in the market.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 33.29%
Debt Cost 6.91%
Equity Weight 66.71%
Equity Cost 9.26%
WACC 8.48%
Leverage 49.91%

11. Quality Control: Redcare Pharmacy NV passed 4 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Fielmann

A-Score: 5.9/10

Value: 4.4

Growth: 5.0

Quality: 7.3

Yield: 4.4

Momentum: 6.0

Volatility: 8.3

1-Year Total Return ->

View Full Report
Stock-Card
Virbac

A-Score: 4.9/10

Value: 3.3

Growth: 6.3

Quality: 6.5

Yield: 0.6

Momentum: 6.0

Volatility: 6.7

1-Year Total Return ->

View Full Report
Stock-Card
Sobi

A-Score: 4.8/10

Value: 2.8

Growth: 7.3

Quality: 5.5

Yield: 0.0

Momentum: 7.0

Volatility: 6.0

1-Year Total Return ->

View Full Report
Stock-Card
Camurus

A-Score: 4.7/10

Value: 0.2

Growth: 9.3

Quality: 9.1

Yield: 0.0

Momentum: 7.0

Volatility: 2.3

1-Year Total Return ->

View Full Report
Stock-Card
Synlab

A-Score: 4.2/10

Value: 5.7

Growth: 8.0

Quality: 3.8

Yield: 1.9

Momentum: 4.0

Volatility: 1.7

1-Year Total Return ->

View Full Report
Stock-Card
Redcare Pharmacy

A-Score: 3.0/10

Value: 6.4

Growth: 6.9

Quality: 3.2

Yield: 0.0

Momentum: 0.5

Volatility: 1.0

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

39.3$

Current Price

39.3$

Potential

-0.00%

Expected Cash-Flows